This topic contains a solution. Click here to go to the answer

Author Question: When did early sociologists begin to turn their attentions to cities? a. the late 17th century ... (Read 53 times)

OSWALD

  • Hero Member
  • *****
  • Posts: 580
When did early sociologists begin to turn their attentions to cities?
 
  a. the late 17th century
  b. the mid-18th century
  c. the late 19th century
  d. the mid-20th century

Question 2

What city did Richard Henry Dana allude to in his classic Two Years Before the Mast?
 
  a. New York
  b. Pittsburgh
  c. Boston
  d. San Francisco



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

essyface1

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

c

Answer to Question 2

d




OSWALD

  • Member
  • Posts: 580
Reply 2 on: Aug 4, 2018
Excellent


upturnedfurball

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Gracias!

 

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library